Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,863.00
Bid: 2,869.00
Ask: 2,871.00
Change: -22.00 (-0.76%)
Spread: 2.00 (0.07%)
Open: 2,892.00
High: 2,896.00
Low: 2,847.00
Prev. Close: 2,885.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Action Capital Markets Seminar & portfolio update

18 Mar 2021 07:00

RNS Number : 6369S
3i Group PLC
18 March 2021
 

Press release

18 March 2021

 

3i Group plc

Action Capital Markets Seminar and portfolio update

 

3i will be holding a Capital Markets Seminar this morning, involving a presentation from the management team of Action, our largest portfolio company. Presentation materials will be made available on 3i's website (www.3i.com) from 09:30 today. An on-demand webcast of the seminar will also be available on our website at the end of the day.

 

The lockdown situation across Europe remains fluid and Action's trading performance in 2021 continues to reflect restrictions in a number of countries. All but 18 stores in France, and all stores in Belgium, Luxembourg, Austria and Poland are fully open and trading strongly while stores in the Netherlands, Germany and the Czech Republic are still operating under different forms of lockdown restrictions. France, Belgium, Luxembourg and Poland have traded very strongly since the start of the year with sales and EBITDA materially ahead of budget and like for likes at least 25% ahead of 2020 for the first 10 weeks of the year.

 

Action lost significant sales compared to budget in the Netherlands and Germany in January and February, although the recent relaxation of restrictions has lifted trading in March which is now moving up to budget levels in both countries. Product availability across all countries is good and the Distribution Centre network is operating well.

 

Current cash and liquidity at Action is at c. €525 million and the business is on course to open a higher number of stores in Q1 2021 than the same period last year.

 

The remainder of the Private Equity portfolio continues to demonstrate resilient performance and has significant momentum moving into the next financial year, with a number of our portfolio companies benefiting from a shift in societal trends towards e-commerce, health and hygiene and value for money retail.

 

Over the course of the financial year, we have seen a reversal in foreign exchange, as sterling has strengthened against both the euro and US dollar. As noted in our Q3 performance update, based on the balance sheet as at 31 December 2020, a 1% movement in the euro and US dollar results in a total return movement of £62 million and £13 million respectively, net of any hedging.

 

 

- Ends -

 

 

For further information, contact:

 

3i Group plc

 

Silvia Santoro

Investor enquiries

 

Kathryn van der Kroft

Media enquiries

 

 

 

Tel: +44 20 7975 3258

Email: silvia.santoro@3i.com

 

Tel: +44 20 7975 3021

Email: kathryn.vanderkroft@3i.com

 

 

 

Notes to editors:

 

About 3i Group

 

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Our core investment markets are northern Europe and North America.

 

For further information, please visit: www.3i.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUBVRRAKUOAUR
Date   Source Headline
29th Mar 20181:59 pmRNSDirector/PDMR Shareholding
9th Mar 20188:30 amRNSAction refinancing and Capital Markets seminar
28th Feb 20183:44 pmRNSTotal Voting Rights
28th Feb 20183:44 pmRNSDirector/PDMR Shareholding
1st Feb 20183:51 pmRNSDirector/PDMR Shareholding
1st Feb 20187:00 amRNSFY2018 Q3 performance update
31st Jan 20184:17 pmRNSTotal Voting Rights
31st Jan 20184:16 pmRNSDirector/PDMR Shareholding
2nd Jan 20184:15 pmRNSPortfolio Update
19th Dec 20173:18 pmRNSTotal Voting Rights
19th Dec 20173:15 pmRNSDirector/PDMR Shareholding
12th Dec 20173:05 pmRNSBlock listing Interim Review
6th Dec 201711:13 amRNSDirector/PDMR Shareholding
5th Dec 201712:00 pmRNSDirector/PDMR Shareholding
4th Dec 201710:32 amRNSDirector Declaration
30th Nov 20173:29 pmRNSTotal Voting Rights
30th Nov 20173:28 pmRNSDirector/PDMR Shareholding
16th Nov 201712:19 pmRNSDoc re. Half Yearly Report 2017
16th Nov 20177:00 amRNS3i Group Half-year results to 30 September 2017
31st Oct 20173:54 pmRNSDirector/PDMR Shareholding
31st Oct 20173:53 pmRNSTotal Voting Rights
3rd Oct 201712:37 pmRNSPortfolio Update
29th Sep 20173:51 pmRNSTotal Voting Rights
29th Sep 20173:50 pmRNSDirector/PDMR Shareholding
18th Sep 20178:30 amRNSPrivate Equity Capital Markets Seminar
31st Aug 20173:48 pmRNSTotal Voting Rights
31st Aug 20173:46 pmRNSDirector/PDMR Shareholding
31st Jul 20174:41 pmRNSTotal Voting Rights
31st Jul 20174:36 pmRNSDirector/PDMR Shareholding
28th Jul 20174:12 pmRNSDirector/PDMR Shareholding
26th Jul 20173:14 pmRNSDirector/PDMR Shareholding
26th Jul 20177:00 amRNSQ1 Performance update
6th Jul 20173:24 pmRNSPortfolio Update
30th Jun 20174:28 pmRNSDirector/PDMR Shareholding
30th Jun 20173:18 pmRNSTotal Voting Rights
30th Jun 20173:17 pmRNSDirector/PDMR Shareholding
29th Jun 20172:54 pmRNSResult of AGM
29th Jun 20172:35 pmRNSDoc re. AGM Resolutions
29th Jun 20172:25 pmRNSDirector/PDMR Shareholding
19th Jun 20174:19 pmRNSDTR 6.3.5
13th Jun 201711:26 amRNSDirector/PDMR Shareholding
12th Jun 20174:48 pmRNSBlock listing Interim Review
2nd Jun 201711:16 amRNSDirector/PDMR Shareholding
31st May 20174:25 pmRNSTotal Voting Rights
31st May 20174:21 pmRNSDirector/PDMR Shareholding
31st May 201710:12 amRNSDoc re. 2017 Annual Report and Accounts
30th May 20178:30 amRNSPrivate Equity Capital Markets Seminar
18th May 20172:49 pmRNSDirector/PDMR Shareholding
18th May 20179:41 amRNSDirector/PDMR Shareholding
18th May 20177:00 amRNSResults for the year to 31 March 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.